How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?
about
Treatment of Helicobacter pylori infection: Current and future insightsAntibiotic treatment for Helicobacter pylori: Is the end coming?Helicobacter pylori: Effect of coexisting diseases and update on treatment regimensSystematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events.Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts.Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Effect of bacterial and host factors on Helicobacter pylori eradication therapyEmerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Helicobacter pylori Infection in the Dominican Republic.Review article: the global emergence of Helicobacter pylori antibiotic resistance.Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype.Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.Quinolone-containing therapies in the eradication of Helicobacter pyloriUse of probiotics in the fight against Helicobacter pylori.Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'.In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains.Adding ofloxacin to standard triple-drug regimens increased the Helicobacter pylori eradication rate: Data from randomized clinical trial.A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysis.Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection.Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera® ) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study.The diagnosis and management of H. pylori infection in Singapore.Role of concomitant therapy for Helicobacter pylori eradication: A technical note.Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis.The Changing Profile of Helicobacter pylori Antibiotic Resistance in Singapore: A 15-Year Study.Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.Reply to letter to the editor: "The dosage of rifabutin in H. pylori eradication regimen should be appropriately determined in each area of the world"Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of "Geographic Weight".Selecting the optimum first-line treatment for H. pylori eradication.Flagellin glycosylation with pseudaminic acid in Campylobacter and Helicobacter: prospects for development of novel therapeutics.Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis.Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis.Current Status of the Third-Line Helicobacter pylori Eradication.
P2860
Q26769707-37F5DD4E-355C-4F2C-9151-FC14C9579850Q26777623-0A935F99-F120-4072-96E0-DB8F7C0138F6Q26777635-8413E658-77AA-40F6-A2E2-4FADEA1D41D5Q27322371-9054BB1F-4335-4B06-9ED2-49CE431ABB2AQ30250102-ED4A8A84-CDE4-4490-B9A1-2E292DD84524Q30381104-5763880E-8B08-4FBD-AA11-D2A9611D0E83Q34255425-E6D96183-AEA2-40B5-9059-A9E88AA2983AQ35598058-041167DD-D445-4B16-96B2-F4FA5ACD6C22Q35738262-AD4635FB-2537-4D18-8ABE-37CBE6151511Q36181286-AC16010C-7905-49E3-B724-AF9D819B7B1DQ36209645-DAA763A3-1875-4C3B-87DC-62949CD512F5Q36279412-3343DB38-F796-4A04-BA33-1169663241C7Q37340339-45E9CA91-5A93-494A-B5EC-2E1D7F398497Q37724709-60315E7A-809F-48AA-94F9-7071EAA8C48BQ38238746-28A046E9-ED54-4764-9F83-3367CB611AC9Q38253054-49E77357-FD6F-4F94-8075-7098E11488D6Q38268663-B4B318EE-3CCB-486C-A6CF-E8CA856BBEA4Q38496942-372783DC-AC08-411F-95BD-94E2DBBF3FECQ38542168-24572358-2BE9-45AA-980F-F8ADD53BB1FDQ38650879-46C89943-AA10-4AAD-92BF-FD49C3FE5063Q38681846-3462CA13-3D7F-41CE-8012-142BAD1A5AD1Q38888977-7381964D-CF43-4649-B84C-7037FCA99976Q38951065-20C4C772-E043-40BF-8BB1-DE75F397ABDCQ39401436-E470097B-4CF9-4B15-ABD9-AFC9E72A1A20Q40108161-B426384D-828F-41F9-B11D-2C44B02B5A66Q40201360-46EAA05A-C317-49B2-B7F8-2847202C22F0Q40482860-A71D3ED8-686A-4A59-A99D-85FC82AC10A1Q40521935-379D373D-8BAA-4892-80EB-4A4AB43EEF83Q40831117-EA332ABB-F3BD-496C-A039-A44FC175BA67Q40892650-1A4D883C-BD33-41B8-AC01-33AAF6D56585Q40957363-6D66DEB8-330C-46B0-BF94-9965D3388537Q41941999-250C711A-891D-4734-A79A-B9D794695C95Q42362197-B0E1805C-553E-40F3-AEFB-36AF2FDBB611Q42530823-BF70A3F0-E9C4-4237-B9C3-27B46E39012DQ42585477-1276A84C-3EB8-4AEF-BD0C-785E0431E08DQ42682684-4E631100-E0DD-48FD-8C4B-2619D9192338Q46272852-32F9036D-861B-4222-A7E1-4B295AEBB4BCQ47650511-9C7CDCC6-D75A-428A-AE76-8C3898D0B0F2Q54216833-4264D6F8-DDED-43CB-BBD4-D77778442644Q55056772-5A1D40CD-4D1F-4366-AAF6-CEB1ACA14B30
P2860
How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How antibiotic resistances cou ...... atment: A matter of geography?
@en
How antibiotic resistances cou ...... atment: A matter of geography?
@nl
type
label
How antibiotic resistances cou ...... atment: A matter of geography?
@en
How antibiotic resistances cou ...... atment: A matter of geography?
@nl
prefLabel
How antibiotic resistances cou ...... atment: A matter of geography?
@en
How antibiotic resistances cou ...... atment: A matter of geography?
@nl
P2860
P50
P356
P1476
How antibiotic resistances cou ...... atment: A matter of geography?
@en
P2093
Floriana Giorgio
P2860
P304
P356
10.3748/WJG.V19.I45.8168
P407
P577
2013-12-01T00:00:00Z